Decision Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Keith Berman, 70, of Westlake Village, California, pleaded guilty last December to securities fraud totaling around $28 million. The Justice Department said that from February through December 2020, Berman falsely claimed his Decision Diagnostics company had developed a 15-second test to detect COVID-19 in a finger prick sample of blood when, in reality, no such test existed. "Berman defrauded investors to profit from the pandemic," Nicole Argentieri, head of the Justice Department's criminal division, said in a statement.

Decision Diagnostics (OTCMKTS:DECN – Get Free Report) and Perion Network (NASDAQ:PERI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk. Earnings & Valuation This table compares Decision […]

Perion Network (NASDAQ:PERI – Get Free Report) and Decision Diagnostics (OTCMKTS:DECN – Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, dividends and profitability. Volatility & Risk Perion Network […]

Former CEO and director of Decision Diagnostics Corp., Keith Berman, pleads guilty to securities fraud, wire fraud, and obstruction of an official proceeding.

Zscaler (NASDAQ:ZS – Free Report) and Decision Diagnostics (OTCMKTS:DECN – Free Report) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk. Risk & Volatility Zscaler has a beta of 0.85, […]